Anita G.M. Stam

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Alfons JM van den Eertwegh, Jurjen Versluis, H. Pieter van den Berg et al. · The Lancet Oncology · 2012 · 357 citations

Medicine, Immunology, Oncology +16

Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation

Claudia C. Sombroek, Anita G.M. Stam, Allan J. Masterson et al. · The Journal of Immunology · 2002 · 202 citations · Full text

Life Sciences, Immunology, Oncology +16

Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study

Hester J. Scheffer, Laurien G. P. H. Vroomen, Marcus C. de Jong et al. · Radiology · 2016 · 139 citations

Medicine, Oncology, Surgery +17

Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation

Hester J. Scheffer, Anita G.M. Stam, Bart Geboers et al. · OncoImmunology · 2019 · 112 citations · Full text

Life Sciences, Immunology, Oncology +17

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

Saskia J. Santegoets, Anita G.M. Stam, Sinéad M. Lougheed et al. · Journal for ImmunoTherapy of Cancer · 2014 · 106 citations · Full text

Medicine, Immunology, Oncology +17